Safety and efficacy of topical testosterone in breast cancer patients receiving ovarian suppression and aromatase inhibitor therapy
The project was submitted and approved through the hospital's SGPP platform in 11/26/2019 (Project No. SGPP 393819) and CAAE (Research Ethics Committee) (CAAE No 25609719.5.0000.007).
Authors
- Antônio C. Buzaid (ORCID: https://orcid.org/0000-0002-1674-4579)
- Gustavo Schvartsman (ORCID: https://orcid.org/0000-0001-6601-3726)
- Patrícia Taranto (ORCID: https://orcid.org/0000-0002-5199-6085)
- Luciano de Melo Pompei (ORCID: https://orcid.org/0000-0001-7084-037X)
- Alessandro Leal (ORCID: https://orcid.org/0000-0001-7967-3213)
- Rafael Aliosha Kaliks Guendelmann
- Diogo de Brito Sales
- Fernando Cotait Maluf (ORCID: https://orcid.org/0000-0001-6122-1374)
Institutions
- Hospital Israelita Albert Einstein (BR)
- NYU Langone Health (US)
- Beneficência Portuguesa de São Paulo (BR)
- Faculdade de Medicina do ABC (BR)
Publication Details
- Journal
- Breast Cancer Research
- Published
- 2024-09-16
- DOI
- https://doi.org/10.1186/s13058-024-01886-7
- Citations
- 7
- Primary Topic
- Cancer survivorship and care
- Type
- article
- Field-Weighted Citation Impact
- 1.98
Funders
- Sociedade Beneficente Israelita Brasileira Albert Einstein